Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tomasz Olczyk
Observed name:
T. Olczyk
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
Jagiellonian University,
Medical University of Silesia,
Centrum Onkologii,
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0003-3834-6528
Observed ORCID:
0000-0003-3834-6528
OpenAlex ID:
A5012152607
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
2009
·
Daria Handkiewicz-Junak
, Jozef Roskosz
, et al.
·
Thyroid Research
·
66
PDF
Rekomendacje Polskich Towarzystw Naukowych „Diagnostyka i leczenie raka tarczycy”. Aktualizacja na rok 2018
2018
·
Barbara Jarząb
, Marek Dedecjus
, et al.
·
Endokrynologia Polska
·
62
PDF
Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer
2015
·
Jolanta Krajewska
, Tomasz Olczyk
, et al.
·
Expert Review of Clinical Pharmacology
·
35
Rola medycyny nuklearnej w diagnostyce różnicowej śledzion dodatkowych u chorych po splenektomii
2012
·
Andrea d’Amico
, Anna Cofalik
, et al.
·
Polish Journal of Radiology
·
17
PDF
Treatment with sorafenib in advanced thyroid cancer - a case report.
2010
·
Jolanta Krajewska
, Tomasz Olczyk
, et al.
·
PubMed
·
15
Loss of heterozygosity in 73 human thyroid tumors.
2005
·
Agnieszka Wozniak
, Malgorzata Wiench
, et al.
·
PubMed
·
7
Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years
2024
·
Aleksandra Kropinska
, Aleksandra Ledwon
, et al.
·
Thyroid
·
6
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer
2021
·
Aleksandra Ledwon
, Ewa Paliczka-Cieślik
, et al.
·
Annals of Nuclear Medicine
·
5
PDF
[Indications for surgery of thyroid cancer based on bioptate molecular examination].
2006
·
Elzbieta Gubała
, Tomasz Olczyk
, et al.
·
PubMed
·
2
Recurrence patterns in differentiated thyroid cancer (DTC) following adjuvant radioiodine therapy
2024
·
Aleksandra Ledwon
, Aleksandra Kropińska
, et al.
·
Endokrynologia Polska
·
1
Changes in clinical presentation of paediatric differentiated thyroid cancer (DTC) treated in one centre over 40 years
2023
·
Aleksandra Kropinska
, Aleksandra Ledwon
, et al.
·
Endocrine Abstracts
Adverse effects of tyrosine kinase inhibitors in advanced thyroid carcinoma – a summary of 10-year experience
2020
·
Jolanta Krajewska
, Aleksandra Kukulska
, et al.
·
Endocrine Abstracts
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
2020
·
Aleksandra Kukulska
, Jolanta Krajewska
, et al.
·
Archives of Medical Science
PDF
Management of treatment-related toxicity caused by multi kinase inhibitors administered due to advanced thyroid carcinoma
2017
·
Jolanta Krajewska
, Aleksandra Kukulska
, et al.
·
Endocrine Abstracts
Toxicity of tyrosine kinase inhibitors in the treatment of thyroid cancer - a 10-year experience resume
2016
·
Jolanta Krajewska
, Aleksandra Kukulska
, et al.
·
Endocrine Abstracts
rh-TSH (Thyrogen) aided radioiodine therapy in children and adolescents with DTC
2014
·
Daria Handkiewicz-Junak
, Jozef Roskosz
, et al.
·
Endocrine Abstracts
The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
2013
·
Jolanta Krajewska
, Aleksandra Kukulska
, et al.
·
Thyroid Research
PDF
Efficacy and safety of radioiodine in the treatment of disseminated differentiated thyroid cancer (DTC) in children
2009
·
D. Handkiewicz-Junak
, J. Roskosz
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
216
H-index:
6
I10-index:
5
Year
Topic
Type